We are live on
!
Find out more
Winslow Capital Management Portfolio holdings
AUM
$25.6B
1-Year Est. Return
33.75%
This Fund
S&P 500
This Quarter
Est. Return
+5.14%
1 Year Est. Return
+33.75%
3 Year Est. Return
+154.66%
5 Year Est. Return
+213.06%
10 Year Est. Return
+1,176.94%
AUM
$27.8B
AUM Growth
+$106M
(+0.38%)
Cap. Flow
-$795M
Cap. Flow
% of AUM
-2.86%
Top 10 Holdings %
Top 10 Hldgs %
52.21%
Holding
65
New
10
Increased
14
Reduced
35
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mercado Libre
MELI
|
+$389M |
| 2 |
Stryker
SYK
|
+$366M |
| 3 |
Starbucks
SBUX
|
+$311M |
| 4 |
Tesla
TSLA
|
+$303M |
| 5 |
Oracle
ORCL
|
+$302M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$487M |
| 2 |
Visa
V
|
+$427M |
| 3 |
Idexx Laboratories
IDXX
|
+$343M |
| 4 |
Parker-Hannifin
PH
|
+$337M |
| 5 |
NVIDIA
NVDA
|
+$333M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 48.97% |
| 2 | Consumer Discretionary | 15.44% |
| 3 | Communication Services | 14.24% |
| 4 | Healthcare | 8.13% |
| 5 | Industrials | 6.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Vanguard Morningstar Growth ETF
VUG
$231B
| $972K | ﹤0.01% |
15,186
+4,290
| +39% | +$266K |
|
52
Costco
COST
$420B
| $905K | ﹤0.01% |
1,021
-379,084
| -100% | -$329M |
|
|
53
Visa
V
$677B
| $845K | ﹤0.01% |
3,072
-1,578,080
| -100% | -$427M |
|
54
UnitedHealth
UNH
$370B
| $744K | ﹤0.01% |
1,272
-503,959
| -100% | -$285M |
|
55
Linde
LIN
$226B
| $720K | ﹤0.01% |
1,510
-136
| -8% | -$62.1K |
|
56
Salesforce
CRM
$158B
| $715K | ﹤0.01% |
2,612
-83,924
| -97% | -$21.5M |
|
57
MSCI
MSCI
$40.9B
| $421K | ﹤0.01% |
723
-98
| -12% | -$53.1K |
|
58
Analog Devices
ADI
$190B
| $374K | ﹤0.01% |
1,625
-382
| -19% | -$86.1K |
|
|
59
Idexx Laboratories
IDXX
$46.2B
| $358K | ﹤0.01% |
709
-706,912
| -100% | -$343M |
|
60
Moody's
MCO
$82.7B
| $337K | ﹤0.01% |
710
-51
| -7% | -$23.6K |
|
61
Vertex Pharmaceuticals
VRTX
$126B
| $240K | ﹤0.01% |
516
-6
| -1% | -$2.88K |
|
62
Abbott
ABT
$187B
| – | – |
-2,894,590
| Closed | -$301M |
|
63
Ametek
AME
$58.2B
| – | – |
-1,629,980
| Closed | -$272M |
|
|
64
Edwards Lifesciences
EW
$51.7B
| – | – |
-5,270,590
| Closed | -$487M |
|
65
Schwab US Large-Cap Growth ETF
SCHG
$62.8B
| – | – |
-35,192
| Closed | -$887K |
|
Similar funds
UIM
VAI
KK
Winslow Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Winslow Capital Management held 65 positions worth $27.8B, up 0.38% from $27.7B the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Winslow Capital Management's Q3 2024 filing shows 10 new, 14 increased, 35 reduced and 4 closed positions. Its largest new stake was Mercado Libre: 206,652 shares worth $424M. The largest sale was Edwards Lifesciences, an estimated $487M.
By sector, the portfolio is most concentrated in Technology at 49% of assets, up from 48% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Winslow Capital Management's largest Q3 2024 buy was Mercado Libre: 206,652 shares worth $424M.
- Winslow Capital Management added most to Texas Instruments in Q3 2024, an estimated $268M increase.
- Winslow Capital Management's biggest Q3 2024 reduction was Visa, cutting an estimated $427M.
- Winslow Capital Management fully exited Edwards Lifesciences in Q3 2024, selling an estimated $487M.
- Winslow Capital Management's ten largest holdings make up 52% of its $27.8B portfolio in Q3 2024.
- Winslow Capital Management opened 10 new positions and closed 4 in Q3 2024.
- Winslow Capital Management's portfolio value rose 0.38% quarter-over-quarter to $27.8B.
Based on Winslow Capital Management's 13F filing for Q3 2024, filed 13 Nov 2024.